Effectivness of a new conductive prewarming system to prevent perioperativ hypothermia in ENT surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004523

Enrollment

Registered

2012-11-02

Start date

2012-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T68 R68.0

Interventions

Group 1: prewarming 30 min prior to surgery and throughout surgery with a new conductive heating system (Barrier ® EasyWarm®, Mölnlycke, Erkrath). Group 2: no prewarming, isolation with standard hospi

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: • BMI 20-30 kg/m2 • ASA I-III • procedure time 60-180 minutes • Anesthetics: midazolam, remifentanil, propofol, rocuronium, and sevoflurane

Exclusion criteria

Exclusion criteria: • adipositas permagna • ASA IV-V • hypo- or hyperthyroidism • fever, infectious disease • pregnancy • procedure time 180 minutes • allergie to midazolam, remifentanil, propofol, rocuronium, or sevoflurane

Design outcomes

Primary

Measure	Time frame
Duration, degree and incidence of perioperative hypothermia will be measured with an esophageal and forehead temperature probe every 15 minutes.	—

Secondary

Measure	Time frame
incidence of postoperativ hypothermia; PACU length of stay	—

Countries

Germany

Contacts

Public ContactIvo Brandes

Zentrum für Anästhesiologie, Rettungs- und Intensivmedizin

ibrande@gwdg.de+49 551 396051

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026